U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Drug Development Tool (DDT) Qualification Programs
  5. Clinical Outcome Assessment (COA) Qualification Program
  6. DDT COA #000076: TUMMY-CD
  1. Clinical Outcome Assessment (COA) Qualification Program

DDT COA #000076: TUMMY-CD

Clinical Outcome Assessments (COA) Qualification Submissions
Office of Immunology and Inflammation (OII)
Division of Gastroenterology (DG)

DDT COA Number
DDT COA #000076

Instrument Name
TUMMY-CD

Disease/Condition
Crohn’s disease (CD)

Concept of Interest
Signs and symptoms of CD

Context of Use
Pediatric patients with CD

COA Type
PRO

Qualification Stage
Letter of Intent-Accepted

Requestor(s)
Anthony Otley

Contact(s)
Anthony Otley

Date Accepted into CDER’s COA Qualification Program
July 9, 2015

Submission and Regulatory Correspondence History

Qualification Submission

Date

FDA Submission Decision & Recommendations

Date

--

--

Transition Letter to 507 Process

9/5/19

Back to Top